Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evolving concepts in the systemic adjuvant treatment of breast cancer.

× No keyword cloud information.

23 in total

Review 1. Dose-intensified treatment of breast cancer: current results.

Authors: C von Schilling; F Herrmann
Journal: J Mol Med (Berl) Date: 1995-12 Impact factor: 4.599

2. Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium.

Authors: Konstantinos Papadimitriou; Konstantinos Papademetriou; Alexandros Ardavanis; Panteleimon Kountourakis
Journal: J Thorac Dis Date: 2010-09 Impact factor: 2.895

Review 3. Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors: H M Bryson; G L Plosker
Journal: Pharmacoeconomics Date: 1993-07 Impact factor: 4.981

4. Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer.

Authors: Ji-Yeon Kim; Eunjoo Jeon; Soonhwan Kwon; Hyungsik Jung; Sunghoon Joo; Youngmin Park; Se Kyung Lee; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho; Yeon Hee Park; Jin Seok Ahn; Young-Hyuck Im
Journal: Breast Cancer Res Treat Date: 2021-07-05 Impact factor: 4.872

Review 5. Recent advances in the treatment of breast cancer.

Authors: W J Smellie; N P Sacks
Journal: Postgrad Med J Date: 1994-04 Impact factor: 2.401

6. Excellent response to gemcitabine in a massively pre-treated woman with extensive cutaneous involvement after recurrence of breast cancer.

Authors: J Arends; C Unger
Journal: Invest New Drugs Date: 2001 Impact factor: 3.850

7. [Effect of selenium on the side effect profile of adjuvant chemotherapy/radiotherapy in patients with breast carcinoma. Design for a clinical study].

Authors: K Schumacher
Journal: Med Klin (Munich) Date: 1999-10-15

8. Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).

Authors: Vega Iranzo; Rafael Sirera; Alfredo Carrato; Andrea Cabrera; Eloísa Jantus; Ricardo Guijarro; Elena Sanmartín; Ana Blasco; Mireia Gil; Lorenzo Gómez-Aldaraví; José Luis González-Larriba; Bertomeu Massuti; Amalia Velasco; Mariano Provencio; Rafael Rossell; Carlos Camps
Journal: Clin Transl Oncol Date: 2011-06 Impact factor: 3.405

Review 9. Oral alkylating agents for breast cancer therapy.

Authors: J A O'Shaughnessy
Journal: Drugs Date: 1999 Impact factor: 9.546

Review 10. Antimetastatic action of the prostacyclin analogue cicaprost in experimental mammary tumors.

Authors: M R Schneider; M Schirner; R B Lichtner; H Graf
Journal: Breast Cancer Res Treat Date: 1996 Impact factor: 4.872